Angelini Ventures — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Avation Medical manufactures the Vivally System, an FDA-cleared wearable device that uses transcutaneous tibial nerve stimulation to treat overactive bladder and urge urinary incontinence in at-home 30-minute sessions.
Digital HealthHealthtechMedical DevicesValencia, US
Jill Schiaparelli(Executive Officer, Director)Kevin Wasserstein(Director)
BoardThomas Shehab, MD(Director)
Co-investorsArboretum VenturesShangBay Capital LLCAvestria Ventures
Noctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes.
Digital HealthMedical DevicesWellness & FitnessPleasanton, US
Shri Raghunathan(Founder)in
Co-investorsBlue Venture FundsOrbiMedTreo Ventures, LlcZühlke VenturesBridge BankSandbox Clinical Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.